Taken together, our findings reveal that BATF overexpression bypasses the need for CD4+ T cell help and could be harnessed to provide therapeutic benefits by enhancing effector CD8+ T cell survival and anti-tumor functions. The gene discussed is CD4; the disease is neoplasm.